Summary by Futu AI
In a recent transaction, Nadja West, a reporting person for Johnson & Johnson [JNJ], executed a stock transaction on April 25, 2024. The specific details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the transaction were not disclosed. Additionally, the current number of shares held by West after the transaction remains unspecified. This information is crucial for investors tracking insider activity as it can provide insights into the confidence levels of company insiders regarding the firm's future prospects.